Stay updated on ModuLung: Metronomic Treosulfan Clinical Trial
Sign up to get notified when there's something new on the ModuLung: Metronomic Treosulfan Clinical Trial page.

Latest updates to the ModuLung: Metronomic Treosulfan Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a Phase II clinical trial for lung cancer treatments, including detailed eligibility criteria and study design. The only notable addition is the mention of 'ModuLung' and a revision update.SummaryDifference44%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to ModuLung: Metronomic Treosulfan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ModuLung: Metronomic Treosulfan Clinical Trial page.